Ignite Creation Date:
2025-12-24 @ 3:44 PM
Ignite Modification Date:
2025-12-30 @ 12:57 AM
Study NCT ID:
NCT04131192
Status:
TERMINATED
Last Update Posted:
2022-05-06
First Post:
2019-10-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
Sponsor:
Sunshine Lake Pharma Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-09
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-10
First Submit QC Date:
None
Study First Post Date:
2019-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-04
Last Update Post Date:
2022-05-06
Last Update Post Date Type:
ACTUAL